Interviews

Joseph Fuhr, PhD, Discusses Competition for the Growing Biosimilar Market

June 10th 2020

Joseph P. Fuhr Jr, PhD, professor emeritus of economics at Widener University in Chester, Pennsylvania, and an expert on antitrust health economics and pharmacoeconomics discusses how future biosimilar competition will affect consumers and market development.

Ha Kung Wong and April Breyer Menon Discuss Promising and Not-so-Promising Biosimilar Legislation

June 5th 2020

Video

An extended interview with Ha Kung Wong, JD, an intellectual property law attorney and partner at Venable Fitzpatrick in New York and April Breyer Menon, JD, an expert on biosimilar patent law and founder of April Breyer Consulting in Chicago discussing potential biosimilars legislation.

Part 2: Ali McBride Discusses Initiatives to Improve Physician Education on Biosimilars

May 25th 2020

Video

Ali McBride, PharmD, MS, BCOP, clinical coordinator of Hematology and Oncology in the Department of Pharmacy at the University of Arizona Cancer Center and past president of the Association of Community Cancer Centers (ACCC), discusses physician struggles tied to biosimilar utilization, the upcoming initiatives for the ACCC Biosimilars Center, and why physicians should be keeping an eye on biosimilars.

Roman Drai Discusses the Evolution of Russia's Biopharmaceutical Industry

May 19th 2020

Video

Roman Drai, MD, PhD, deputy director and head of clinical operations at Geropharm, discusses how Russia has developed its biopharmaceuticals industry.

Part 1: Ali McBride Discusses ACCC Initiatives and Biosimilar Uptake

May 18th 2020

Video

Ali McBride, PharmD, MS, BCOP, clinical coordinator of Hematology and Oncology in the Department of Pharmacy at the University of Arizona Cancer Center and past president of the Association of Community Cancer Centers (ACCC), discusses the anticipated growth for the US biosimilar market and what the ACCC is doing to further uptake efforts.

Part 2: Jim Koeller Discusses the Complexities of Multiple Biosimilars

May 13th 2020

Video

Jim M. Koeller, MS, a professor of pharmacotherapy and member of the Center for Pharmacoeconomic Studies in the College of Pharmacy at the University of Texas at Austin, discusses the complexities of an institution taking on multiple biosimilars and how payers can make the process easier.

Roman Drai Discusses Geropharm's Biosimilar Pursuits

May 12th 2020

Video

Roman Drai, MD, PhD, deputy director and head of clinical operations at Geropharm, discussed Geropharm’s budding biosimilar pipeline and the company’s international pursuits during the World Biosimilar Congress USA 2020 at the Festival of Biologics USA in San Diego, California.

Part 1: Jim Koeller Talks Payer Influence on Biosimilars

May 11th 2020

Video

Jim Koeller, a professor of pharmacotherapy and member of the Center for Pharmacoeconomic Studies in the College of Pharmacy at the University of Texas at Austin, discusses how payers influence biosimilar prescriptions and the pressure to lower drug costs for patients.

Part 3: Axinn Attorneys Discuss Patent Exclusivity and the BPCIA

May 8th 2020

Video

Ted Mathias and Stacie Ropka, PhD, both patent attorneys and partners at Axinn, Veltrop and Harkrider LLP, discuss patent exclusivity for biological drugs and other important issues that need to be addressed whether or not the ACA and the Biologics Price Competition and Innovation Act (BPCIA) are ruled invalid.

Part 2: Axinn Patent Attorneys Discuss Fallout From Challenges to the ACA

May 6th 2020

Video

Ted Mathias and Stacie Ropka, PhD, patent attorneys and partners at Axinn, Veltrop, and Harkrider LLP, discuss past and future court decisions that leave the Affordable Care Act (ACA) in jeopardy and what could happen to the Biologics Price Competition and Innovation Act (BPCIA) as a result.